ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 192 filers reported holding ARCUS BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,785,070 | +3.3% | 379,847 | +28.1% | 0.23% | +17.3% |
Q1 2024 | $5,599,242 | +27.0% | 296,570 | +28.5% | 0.20% | +34.9% |
Q4 2023 | $4,407,841 | +25.5% | 230,777 | +18.0% | 0.15% | +16.8% |
Q3 2023 | $3,511,002 | -45.1% | 195,599 | -37.9% | 0.12% | -36.5% |
Q2 2023 | $6,394,319 | -39.2% | 314,836 | -45.4% | 0.20% | -38.4% |
Q1 2023 | $10,519,884 | +23.9% | 576,748 | +40.5% | 0.32% | +23.1% |
Q4 2022 | $8,488,726 | -5.5% | 410,480 | +19.6% | 0.26% | -11.3% |
Q3 2022 | $8,982,000 | +41.6% | 343,335 | +37.1% | 0.29% | +35.0% |
Q2 2022 | $6,345,000 | -11.1% | 250,385 | +10.8% | 0.22% | +22.6% |
Q1 2022 | $7,134,000 | +28.3% | 226,050 | +64.5% | 0.18% | +55.3% |
Q4 2021 | $5,560,000 | +52.1% | 137,387 | +31.0% | 0.11% | +65.2% |
Q3 2021 | $3,656,000 | – | 104,848 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $30,436,014 | 24.20% |
Decheng Capital LLC | 869,790 | $16,421,635 | 2.20% |
Boxer Capital, LLC | 1,602,200 | $30,249,536 | 1.49% |
DAFNA Capital Management LLC | 231,717 | $4,374,817 | 1.00% |
SECTORAL ASSET MANAGEMENT INC | 93,635 | $1,767,829 | 0.70% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 957,304 | $18,073,900 | 0.67% |
Parkman Healthcare Partners LLC | 259,920 | $4,907,290 | 0.60% |
Woodline Partners LP | 2,883,657 | $54,443,444 | 0.50% |
Granahan Investment Management | 296,570 | $5,599,242 | 0.20% |
PDT Partners, LLC | 97,152 | $1,834,230 | 0.17% |